Skip to the main content

Case report

https://doi.org/10.20471/may.2021.57.01.08

Sarcoidosis and Corticosteroid Therapy: Dilemma from a Psychiatric Point of View

Mohd Amiruddin Mohd Kassim orcid id orcid.org/0000-0003-0681-2117 ; Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia
Ruziana Masiran ; Department of Psychiatry, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia
Nicholas Pang orcid id orcid.org/0000-0003-1659-6374 ; Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia


Full text: english pdf 338 Kb

page 93-98

downloads: 715

cite


Abstract

Introduction and Methods: A man diagnosed with sarcoidosis developed partial retrograde amnesia followed by three months of depressive symptoms with panic attacks, which remitted with an antidepressant and a benzodiazepine. However, three months later hallucinations and overvalued persecutory ideations subsequently emerged, only to show partial response to antipsychotic treatment. Results: Sarcoidosis was treated with corticosteroids but serial thorax imaging shows minimal response. Corticosteroid was onboard throughout treatment, corresponding with non-remission of psychotic symptoms. There are persistent subjective cognitive difficulties but Mini Mental State Exam score is full. He is currently being treated with escitalopram, alprazolam and quetiapine. Conclusion: This case illustrated the dilemma between prolonging the corticosteroid therapy for sarcoidosis treatment and the psychiatric sequalae. While symptomatic antipsychotic treatment is effective, multi-disciplinary approach is imperative in determining the duration of the corticosteroid therapy.

Keywords

corticosteroid; sarcoidosis; psychosis; amnesia

Hrčak ID:

245984

URI

https://hrcak.srce.hr/245984

Publication date:

20.11.2020.

Article data in other languages: croatian

Visits: 2.477 *